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Interaction networksModel organisms provide opportunities to design research experiments focused on disease-related pro-
cesses (e.g., using genetically engineered populations that produce phenotypes of interest). For some dis-
eases, there may be non-obvious model organisms that can help in the study of underlying disease
factors. In this study, an approach is presented that leverages knowledge about human diseases and asso-
ciated biological interactions networks to identify potential model organisms for a given disease cate-
gory. The approach starts with the identiﬁcation of functional and interaction patterns of diseases
within genetic pathways. Next, these characteristic patterns are matched to interaction networks of can-
didate model organisms to identify similar subsystems that have characteristic patterns for diseases of
interest. The quality of a candidate model organism is then determined by the degree to which the iden-
tiﬁed subsystems match genetic pathways from validated knowledge. The results of this study suggest
that non-obvious model organisms may be identiﬁed through the proposed approach.
 2013 Elsevier Inc. All rights reserved.1. Introduction
Complex diseases stem from an interplay of genetic and envi-
ronmental factors. At the genetic level, these diseases are often
associated with the dysfunction of more than one gene. This neces-
sitates the study of complex diseases at a systems level, which in-
cludes the modeling of cellular processes that underlie an observed
disorder and may involve both sequential and simultaneous
molecular interactions between many agents (e.g., genes and
chemical compounds). This highlights the importance of curating
molecular interaction networks (e.g., gene/protein interaction net-
works, metabolic networks, and genetic pathways). Data resources
that catalogue these networks are increasing both in terms of the
number and size of networks as well as their coverage of organ-
isms. Environmental factors, on the other hand, complicate the
study of human diseases, since it is difﬁcult to create a controlled
environment that enables scientists to study environmental effects
on disease development. Hence, model organisms offer opportuni-
ties for detailed study of features associated with complex dis-
eases, because these organisms may be genetically engineered to
produce desired phenotypes (e.g., associated with a particulardisease of interest) and can be studied more easily in a controlled
environment.
Model organisms play a vital role in advancing knowledge
about disease processes. The sophisticated genetics of human dis-
eases makes it important to study model organisms to uncover
underlying mechanisms of diseases. Model organisms may not
necessarily be closely related to humans from an evolutionary per-
spective. For instance, yeast are regularly used to model disease
states [1]. Comparison of different phenotypes that arise from a
conserved set of genes can be important for exploring model
organisms for speciﬁc human disorders or diseases [2,3]. Analysis
of model organism microarray data may also help identify those
that have disease-related genes differentially expressed [2].
The house mouse (Mus musculus) has been a typical model
organism in the study of human disease processes [4], as well as
complex traits and social behavior [5]. Mice have also been genet-
ically engineered to provide models for studying cancer and im-
mune diseases [6,7]. However, mice may not always be suitable
for the study of all categories of disease. In a recent study of
‘phenologs’ (phenotypes that are equivalent across organisms),
McGary et al. suggested a worm model (Caenorhabditis elegans)
for breast cancer, a mouse model for autism, a plant model (Arabid-
opsis thaliana) for Waardenburg syndrome, and a yeast model
(Saccharomyces cerevisiae) for angiogenesis disorders [3]. Thus,
there may be many potential choices for a suitable model organism
relative to the spectrum of phenomena associated with disease. An
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organism(s) that might provide insights to human diseases.
Evaluation of candidate model organisms might be measured
by the degree to which gene/protein interaction networks include
pathways that are structurally and functionally similar to human
disease-related biological processes. To this end, prediction of
pathways in candidate model organisms that are similar to dis-
ease-related pathways in humans can be effective in evaluating
model organisms. Pathway prediction can be performed by a vari-
ety of techniques. A widely used technique involves mining gene or
protein interaction networks to extract dense subgraphs (highly
connected components within the network) and then calculating
the statistical signiﬁcance of the discovered subgraphs [8]. Statisti-
cally signiﬁcant subgraphs are then cast as predicted pathways.
Tian et al. developed a method to discover statistically signiﬁcant
pathways from gene expression data [9]. Bebek and Yang anno-
tated gene networks with GO annotations and developed the Path-
Finder method to predict novel pathways [10]. Cakmak and
Ozsoyoglu developed a method that used frequent functional pat-
terns in a known pathway to ﬁnd organism-speciﬁc versions of
that pathway in the gene networks [11]. Finally, Senf and Chen
developed a hidden Markov model-based method to identify genes
participating in genetic pathways [12].
The present study proposes a computational method that at-
tempts to provide a quantitative measure of how well a candidate
model organism might be suited for the study of a given disease
type. The proposed quantitative measure is based on the propor-
tion of correctly predicted genetic pathways that can be identiﬁed
in interaction networks for a given organism. The proposed ap-
proach makes use of three types of knowledge resources: (1) Kyoto
Encyclopedia of Gene and Genomes (KEGG) [13] pathway data-
base, (2) The Biological General Repository for Interaction Datasets
(BioGRID) and Search Tool for the Retrieval of Interacting Genes/
Proteins (STRING) gene/protein interaction databases [14], and
(3) Gene Ontology (GO) [15] annotations that have been applied
to genes or proteins in curated databases. The main premise of this
work was to leverage a machine learning method to extract signif-
icant functional and structural patterns, or ‘ﬁngerprints,’ [16] from
functionally annotated KEGG disease pathways and match these
patterns to functionally annotated gene/protein interaction net-
works in major databases (e.g., BioGRID) as well as meta-databases
(e.g., STRING). Depending on an organism’s interaction network
coverage of structural patterns for a given disease, it can be ranked
in terms of model organism suitability for that disease. Through
the use of a statistical model, this study was able to quantify the
dependency of functional structural patterns in pathways and dis-
ease categories for 14 organisms. It was assumed that some species
may be a better suitable model for one disease category and thus
less suitable for studying other diseases. This assumption was
motivated by the McGary et al. study, where a range of model spe-
cies were suggested for complex diseases [3]. The promising re-
sults suggest that the described approach may be used to
determine the potential for a given organism to serve as a model
for the study of a particular disease.2. Materials and methods
In this section, the ﬁve phases of the developed approach are
described: (1) annotation of gene/protein nodes in pathway graphs
with molecular function annotations, (2) learning disease ﬁnger-
prints within annotated pathways, (3) functional annotation and
indexing of gene/protein interaction networks, (4) prediction of
novel subsystems within gene/protein interaction networks using
learned ﬁngerprints, and (5) scoring discovered subsystems using
reference pathways. Fig. 1 provides an overview of the approach.2.1. Functional annotation of KEGG pathways
KEGG genetic pathways are modeled as directed graphs with a
node set (V) representing biochemical entities such as genes,
chemical compounds, and protein complexes and an edge set (E)
representing interaction relations between entities such as general
process type (e.g., a gene expression [GErel] or protein interaction
[PPrel] relation) and speciﬁc relation types (e.g., activation, expres-
sion, and inhibition). For this study, only gene/protein nodes were
considered. To increase the generalization capability, gene nodes
were enriched with molecular function annotations as deﬁned in
Gene Ontology (GO) [15]. These GO annotations were imported
from Human Protein Reference Database (HPRD) [17] and overlaid
on gene/protein nodes of pathway graphs. Gene/protein nodes
without a match to HPRD GO annotations were assigned a default
‘NULL’ annotation. Nodes could be associated with multiple GO
term annotations and edges could also have multiple labels. Thus,
for each graph there was a shift of focus from ‘‘what gene/protein is
in a given node?’’ to ‘‘what function does the node perform in a
system that models a biological process?’’ With knowledge-
enriched annotations of genes/proteins, pathways were repre-
sented at a functional level. Subsequently, functional structural
patterns in these pathways graphs could be matched to sub-
networks of large interaction networks with functionally anno-
tated nodes. In this study, the KEGG disease pathways dataset
contained 63 disease pathways across seven human disease
classes. KEGG disease pathways cover many biological processes
related to genetic information processing, metabolism, and cellular
processes. However, this study did not focus on a particular path-
way category such as metabolic pathways and cellular processes.
Each graph instance in this design set was associated with a class
label from the seven disease classes in KEGG.2.2. Learning disease ﬁngerprints
The objective of the second module of the proposed method
was to identify characteristic biological functionality patterns,
termed ‘‘ﬁngerprints,’’ in annotated disease pathways. A mathe-
matical model and an algorithm were designed to accomplish this
task. A disease ﬁngerprint was deﬁned as a subgraph within a GO
annotated disease pathway. Fingerprints were assumed to repre-
sent functional sub-processes that could be characteristic of a dis-
ease class such as immune, infectious, or neurodegenerative
disease. Graphs in the design dataset were assumed to be indepen-
dent and identically distributed (iid) data observed from an un-
known probability distribution P(G). The iid data assumption was
made to facilitate statistical inference and to make decision about
properties (e.g., class label) of a graph instance independent of
other graph instances in the dataset. For a given GO-annotated
pathway graph, there can be a large number of possible GO func-
tionality subgraph patterns, which will be called ‘‘subgraph pat-
terns’’ hereafter. A mathematical model was proposed to allow
for scoring of subgraph patterns. High scoring patterns were out-
put from the model as disease ﬁngerprints.
Mining of key subgraph patterns in the dataset was performed
so that a subgraph pattern is evaluated within a context of its
neighboring patterns in a graph. To formalize the idea of neighbor
context, a utility function termed ‘‘graph partitioning function’’
was used to decompose a graph into a set of subgraphs. A parti-
tioning function p: E(G)? Z assigned an integer to every edge e
of graph edge set E(G) such that edges with the same integer
formed a subgraph. The set of subgraphs Hp that were highlighted
by a speciﬁc partitioning function (p) was deﬁned as
Hp ¼ fgij8e 2 EðgiÞ; EðgiÞ # EðGÞ; pðeÞ ¼ ig. Fig. 2 illustrates the
concept of partitioning.
Fig. 1. Overview of the ﬁve components of the method developed in this study.
Fig. 2. An example graph is partitioned into smaller subgraphs using partitioning functions p1, p2 and p3. The vector representation of each partitioning is presented under
each of the three example partitionings. For instance, partitioning p3 assigns edges 1, 2 to subgraph 1 and edges 3, 4 to subgraph 2. Additional possible partitionings are not
shown.
180 A.R. Nabhan, I.N. Sarkar / Journal of Biomedical Informatics 47 (2014) 178–1912.2.1. Scoring of subgraph patterns within pathways
Typically, there exists a large space of possible partitionings for
a given graph. Searching for the most likely partitionings in the
dataset leads to the identiﬁcation of key subgraph patterns (ﬁnger-
prints). Searching for best graph partitionings can be better than
searching for individual subgraph patterns (e.g., as in frequent pat-
tern mining techniques [18]). This is because a graph partitioning
hypothetically decomposes a system (represented by a graph) into
a set of components (subgraphs), and partitioning quality reﬂects
how good is a partitioning in identifying key components of that
system (pathway in this case).
The search for best partitionings therefore required a scoring
function that could be used to assign a high score to a partitioning
that highlights the most likely patterns. For a pathway graph (G) of
a disease class C and a partitioning p, P(G,p|C) was deﬁned as the
probability of observing a pathway graph G and a partitioning p gi-
ven a disease class C. The value of P(G,p|C) depended on how good
that partitioning highlighted key subgraph patterns. Recall that Hp
was deﬁned as the set of subgraphs according to a partitioning
function p of graph G:
Hp ¼ fgij8e 2 EðgiÞ; EðgiÞ # EðGÞ; pðeÞ ¼ igThe graph partitioning probability P(G,p|C) was then computed
as a function of the set of subgraphs g 2 Hp:
PðG;pjCÞ ¼ Pðg1; g2; . . . ; gnjCÞ ð1Þ
where g1, g2, . . . , gn 2 Hp. Assuming subgraphs resulting from a par-
titioning function were conditionally independent, P(G,p|C) was
written as
PðG;pjCÞ ¼
Y
g2Hp
PðgjCÞ ð2Þ
The probability P(g|C) represented the degree to which a sub-
graph g was a ﬁngerprint of a disease class C. For the purpose of
probability estimation, counting the number of instances of a given
subgraph in partitionings of all graphs in a direct way was deemed
impractical. This was because deciding whether two subgraphs
were the same would require a test of subgraph isomorphism
[19]. An indirect method was thus used to approximate subgraph
matching by representing each subgraph with a set of maximal
paths connecting its nodes. A maximal path was deﬁned as a path
that could not be extended by adding nodes to either end. The
probability P(g|C) could then be expressed in terms of probabilities
Fig. 3. Generating new partitions from an existing graph. (a) There are ﬁve
subgraphs in this partitioning. Edges e1 and e2 belong to different subgraphs but
share node B. Therefore, the partitioning vector is modiﬁed to change membership
of e2 to belong to subgraph containing e1. Similarly, edge e3 was assigned to
subgraph g4. The net effect is in (b) with a partitioning with 3 subgraphs.
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side the subgraphs were used to approximate representation of
subgraphs, and thus avoid subgraph isomorphism test. Each max-
imal path represented a sequence of GO annotations of nodes that
lay in that maximal path. In the case where a node had more than
one GO annotation, multiple maximal paths were generated so that
each maximal path had only one GO annotation per node. Then,
P(g|C) was calculated approximately as:
PðgjCÞ 
Y
a2g
PðajCÞ ð3Þ
where a denotes a GO-annotated maximal path that connected a
subset of nodes inside subgraph g. Using Eqs. (2) and (3), the likeli-
hood of a partitioning and a graph instance given a disease class la-
bel was written as
PðG;pjCÞ ¼
Y
g2Hp
Y
a2g
PðajCÞ ð4Þ
Thus, Eq. (4) represented a scoring function that was used in the
search for best partitionings that highlighted disease ﬁngerprints
within pathway graphs. The problem was then that the probability
distribution of maximal paths P(a|C) did not exist a priori and
needed to be estimated while searching for best partitionings. To
solve this problem, an iterative training algorithm was used (de-
scribed in the next section).
2.2.2. Parameter estimation
The proposed model had a set of parameters h = {P(a|C)} com-
posing entries of the conditional probability table of maximal
paths. The parameter set h needed to be estimated in order to
score graph partitionings. The Expectation Maximization (EM)
[20] algorithm was used to estimate model parameters according
to Eqs. (2)–(4) while identifying the set of best partitionings for
each graph in the pathway dataset. Initially, a set of random par-
titionings was generated and maximal paths within these partit-
ionings were collected and an initial distribution for P(a|C) wascreated. The parameter estimation process for this study had
two basic steps. The ﬁrst step was to search for highly scoring
partitionings using the most recent probability table P(a|C) ob-
tained in the previous iteration of EM. Then, counts of maximal
paths were collected from subgraphs of the set of best partition-
ings obtained. Collected counts were then normalized to produce
a conditional probability model. During searching and scoring of
partitionings, a small probability value was used as a value of
P(a|C) in the case where a maximal path had not been added
yet to the probability table. The EM algorithm was run for four
iterations in this study. Additional details of the mathematical
model and EM parameter estimation procedure are presented in
Appendix A.
The EM algorithm had two outputs: the conditional probability
table P(a|C) and the set of best partitionings of each pathway in the
dataset. Disease ﬁngerprints were extracted from best partition-
ings of pathways. Using the model described above, the search
for disease ﬁngerprints not only depended on an individual score
of a subgraph (according to Eq. (3)), but also based on the contribu-
tions of other subgraphs in the quality of a graph partitionings
(according to Eq. (4)). To test the model, a graph classiﬁer was built
to classify pathways using probability table P(a|C) that was esti-
mated during EM run. This classiﬁcation task served as bench-
marking of the proposed model.
2.2.2.1. Benchmarking of the ﬁngerprint mining method. The efﬁcacy
of the structural pattern analysis method was demonstrated by
implementing a graph classiﬁer for disease pathways that utilized
the conditional probability model estimated during model training.
Given a test set of graphs, the task of the classiﬁer was to assign the
most likely disease class to each graph in a test set.
2.2.2.2. Classiﬁcation of pathways. This classiﬁcation task was mod-
eled mathematically by ﬁnding the value for C that maximized
P(C|G), which represented the probability that C is a disease class
of pathway G. Using Bayes’ theorem:
PðCjGÞ ¼ PðCÞPðGjCÞ
PðGÞ ð5Þ
where P(C) quantiﬁed a priori knowledge about class label distribu-
tion, P(G|C) was deﬁned as the conditional probability of observing
graph G given that its class label was C, and P(G) was the probability
distribution of graphs. The choice of class label did not depend on
P(G). Therefore, Eq. (5) was expressed as
PðCjGÞ1PðCÞPðGjCÞ ð6Þ
Modeling P(G|C) directly would have required counting number
of instances of a graph G. This approach had a practical challenge:
Because each pathway was represented only once in the dataset,
P(G|C) would have followed a uniform distribution with probability
equal to 1/(number of pathways of class C), and that would not
have helped the statistical inference process. An alternative ap-
proach to model P(G|C) that was used in this study was to incorpo-
rate the subgraph patterns in G according to the set of partitioning.
Subgraphs tended to be more frequent in the dataset than their
super graphs. Since one cannot be sure about which partitioning
is the best, P(G|C) was expressed in this study as the sum of best
partitionings for graph G,
PðGjCÞ ¼
X
p
Y
g2Hp
Y
a2g
PðajCÞ ð7Þ
Hence, having a prior distribution P(C) and a conditional proba-
bility P(G|C) that was calculated using partitionings and maximal
paths conditional probability distribution, the classiﬁcation prob-
lem was to ﬁnd a class label C that maximized Eq. (6):
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C
PðCÞPðGjCÞ ð8Þ
During classiﬁcation process, the search for a set of best partition-
ings was performed for each test graph instance (in the same way
it was performed during probability estimation). The classiﬁcation
process started with setting a hypothesized class label C0 for a test
graph. Then, a search for the best partitioning set started with class
label of test graph ﬁxed to C0. Eq. (6) was used to evaluate P(C0|G).
Then, another class label was used as a value for C0, and a new set of
partitionings was searched for and Eq. (6) used to calculate P(C0|G).
The class label that achieved the highest score was reported as clas-
siﬁer output.
After benchmarking the graph structural pattern analysis meth-
od, the next module used the identiﬁed GO functionality patterns
to predict subsystems in the GO-annotated interaction networks
for a set of 14 species. This pattern matching module had two com-
ponents, which are described in the following two subsections.Fig. 4. An example interaction network and an index with keys of GO annotations.
2.3. Functional annotation and indexing of gene/protein interaction
networks
For each species, a network of genetic and protein interactions
was constructed by importing interactions from two sources: Bio-
GRID [14] and STRING [21]. BioGRID data contains curated inter-
actions from high throughput datasets and individual focused
studies. In this study, only interactions within the same species
were included. For some species analyzed in this study, the num-
ber of interactions was limited in BioGRID. To increase coverage
of a species’ interaction network, more interactions were im-
ported from STRING database (version 9.0). STRING provides
information about experimental and predicted interactions. Seven
sources of information about a given interaction are used in
STRING, including: genome context methods, gene co-expression,
text mining, as well as associations known from other database
resources such as BioCyc [22] and PDB [23]. An interaction in
STRING database has a combined score that is computed using
evidence scores from each data source. In this study, for data im-
ported from STRING database, only interactions with combined
score greater than or equal to 70% conﬁdence were used in the
construction of networks. Since ﬁngerprints consisted of only
GO terms (i.e., not gene/protein names) interaction networks of
each species were GO-annotated in order to be suitable to match
disease ﬁngerprints learned from GO-annotated disease path-
ways. Nodes of interaction networks were annotated with molec-
ular function annotations from the AmiGO Gene Ontology
database [24].
In this study, an interaction network of a given species could
have had as many as 12,000 nodes (genes/proteins) and as many
as 50,000 edges (interactions). Network indices were created for
these large networks to enable efﬁcient sub-network searches.
An index of an interaction network was built by generating a
hash table with keys composed of ordered pairs of GO terms with
ﬁrst component being the node identiﬁer of the node being in-
dexed and second component denoting one of its neighbors. Values
in the index table are identiﬁers of nodes with label equal to the
ﬁrst component of the ordered pair key. A value of a given key
can be a single node identiﬁer or a set of node identiﬁers. The index
table was constructed by traversing every node in a given interac-
tion network and examining its neighboring nodes.
Fig. 4 shows an example of GO-annotated interaction network
and its index. In this example, suppose node n1 is to be indexed.
Its neighbor nodes are {n2,n3,n4}. For the pair (n1,n2) the corre-
sponding annotation pair is (GO3,GO1). A key of (GO3,GO1) is in-
serted into the index with value {n1}. Similarly, the key
(GO3,GO2) is inserted with value {n1}. In case a key already exists,values are appended to ones that already exist. For instance, when
indexing node n8 that is annotated with GO3, a key (GO3,GO2) al-
ready exists in the table with value being {n1}. Therefore, the value
set is updated by adding element n8 and the ﬁnal key:value pair
will be (GO3,GO2):{n1,n8}.
2.4. Predicting novel subsystems using disease ﬁngerprints
Disease ﬁngerprints were identiﬁed using the method described
in Section 2.2 were matched to the GO annotated interaction net-
works (with interactions imported from BioGRID and STRING dat-
abases) using a similarity search algorithm. This algorithm used a
network index to ﬁnd subnetworks that matched an input disease
ﬁngerprint. Given a query subgraph and using the network index,
the algorithm went through three steps.
In the ﬁrst step, an initial set of matched node identiﬁers (the
‘‘candidate matching set’’) was retrieved for every node in the
query subgraph. This was performed by using GO terms of nodes
of each edge in the ﬁngerprint subgraph to search the index. The
following is an example to illustrate the pattern matching process
(see Fig. 5). Let v be a node in a query subgraph. For simplicity of
demonstration, presume that each node has only one GO annota-
tion. For every node u with an edge leading to v, an ordered pair
of GO terms ut and vt was used as a key to lookup the network in-
dex. As a result, sets of node identiﬁers values of the corresponding
key were retrieved from the table. For example, as shown in Fig. 5c,
three sets of network node identiﬁers that matched query node v3
(one set per neighbor). The ﬁrst set resulted from the edge (v3,v1),
with a key consisting of (GO3,GO1). By looking the value up in the
index table, the retrieved value was the set {n1}. The second candi-
date set for query node v3 resulted from the edge (v3,v2), with a
key consisting of (GO3,GO2). By looking this value up in the index
table, the retrieved value of this key was the set {n1,n8}. Similarly,
the third candidate set for query node v3 resulted from the edge
(v3,v4), with a key consisting of (GO3,GO4), with {n1} as third can-
didate set for query node v3 (see Fig. 5c). The process was repeated
for every node in the query subgraph.
The second step was to examine candidate node identiﬁer sets
for each query node and to check topological constraints. A mem-
ber in the candidate node set conforms to topological constraints if
it has link to a member of other candidate node sets of neighbor
nodes. Topological constraints were checked ﬁrst by performing
set intersection operation of all candidates sets of a given query
node. For example, the ﬁnal candidate set for query node v3 was
{n1,n8} \ {n1} \ {n1} = {n1}. If the set intersection operation
Fig. 5. The process of matching a query subgraph (GO-annotated nodes) (b) to an interaction network (a). The three steps process start with generating initial candidate set of
network nodes that match the GO terms of query subgraph nodes (c). The second step ([d] and [e]) reﬁnes candidate sets by removing network nodes that do not meet
topological constraints. The last step is to generate an output subnetwork as answer to a query subgraph (f).
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subgraph to any subnetwork in the interaction network, and hence
the search was stopped. Node identiﬁers in the candidate set were
then removed if they did not have any links to any node in candi-
date sets of other neighboring query nodes. For example, the node
identiﬁer n5 in the candidate sets of v2 (see Fig. 5d–e) was
removed from that candidate set, because it was not connected
to any item from candidate set of v3 (n5 was supposed to be con-
nected to n1 according to the query subgraph structure, but in the
interaction network there was no link between node n1 and node
n5). This step was repeated until all network node identiﬁers in
query subgraph candidate sets satisﬁed topological constraints.
The third and ﬁnal step was the generation of a set of sub-
networks from candidate nodes sets of every query subgraph node.
If there was only one node identiﬁer for each candidate sets of
query nodes, then it meant there was only one subnetwork that
matched the input query subgraph. Otherwise, multiple subnet-
workswere returned as amatched set of the query subgraph. Details
of the subgraph matching method are provided in Algorithm 1 of
Appendix B. The output of this algorithm was a set of subnetworks
that served as candidate subsystems that partially or completely
matched known pathways available in literature.Table 1
KEGG disease pathway categories.
Disease category Number of instances
Cancer 17
Infectious disease 22
Substance dependence 5
Neurodegenerative disease 5
Immune disease 7
Cardiovascular disease 4
Metabolic disease 32.5. Scoring candidate subsystems
For each disease category, ﬁngerprints were used to ﬁnd sub-
systems in the interaction network for each of the 14 species. To
evaluate these candidate subsystems, a set of reference pathways
was used to determine the degree of matching between predicted
subsystems and known pathways. A candidate subsystemwas con-
sidered as being predicted correctly if 70% or more of its genes/pro-
teins were found in a known pathway in a reference dataset. The
Wikipathways database [25] was used as reference dataset. As rec-
ommended on the WikiPathways download page, only the analysis
collection pathways were used for evaluation. Schizosaccharomyces
pombe, Escherichia coli and Sus Scrofa had no WikiPathways analy-
sis collection data. Also, since the pathways of Saccharomyces c.S288c and Arabidopsis thaliana in WikiPathways data were mainly
metabolic pathways, they were not used to evaluate the predicted
pathways. Predicted pathways of Escherichia coli and Saccharomy-
ces c. S288c were matched to reference pathways from BioCyc.
Reference pathways for Arabidopsis thaliana were downloaded
from AraPath database [26]. A further detailed evaluation for each
species was reported for each disease of cancer and infectious
disease classes in the design set.3. Results
Evaluation of the developed approach was done in two steps.
The ﬁrst step was to measure the performance of the proposed
mathematical model for structural pattern analysis as a function
of the accuracy of a graph classiﬁer. The second step was to evalu-
ate the predicted subsystems that were discovered by the sub-
graph matching algorithm using a set of ﬁngerprints for each
disease class, and then comparing the discovered subsystems to
known pathways published in the literature.3.1. Datasets
The experiments were performed on disease pathways down-
loaded from KEGG pathway database (in September 2012). The
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seven disease classes. This dataset is summarized in Table 1. The
gene/protein nodes of the pathway dataset were annotated with
GO molecular function terms imported from HPRD database. Inter-
action networks for 14 species were downloaded from the BioGRID
and STRING databases (in October 2012). All networks were anno-
tated with molecular function annotations from AmiGO database.
The GO molecular function hierarchy included a total of 10,286
GO concepts (as of July 2012). To determine the overall accuracy
of the approach presented here, the candidate subsystems identi-
ﬁed in the 14 interaction networks were compared to published
pathways in WikiPathways and BioCyc databases.
3.2. Benchmarking of structural pattern analysis model
Given the set of 63 disease pathways analyzed for this study
from KEGG, two binary classiﬁers were developed: (1) a cancer
classiﬁer and (2) an infectious diseases classiﬁer. Cancer and infec-
tious diseases had the largest number of instances in the design
dataset (17 cancer pathways and 22 infectious diseases pathways,
respectively). Two modiﬁed datasets were created: (1) a cancer
dataset where graph instances were labeled as either associated
with cancer (positive case) or not associated with cancer (negative
case; for this cancer classiﬁer dataset, all non-cancer pathways
such as infectious diseases, immune diseases, and neurodegenera-
tive pathways were labeled negative); and, (2) an infectious dis-
ease dataset where graph instances were labeled as either
associated with infectious disease (positive case) or not associated
with infectious disease (negative case). A threefold cross validation
experiment was performed. The results of classiﬁcation perfor-
mance in terms of the geometric average of sensitivity and speci-
ﬁcity are shown in Table 2. An overall accuracy of 86% was
achieved.
3.3. Assessment of organisms as molecular models
Assessment of organisms as molecular models was performed
by matching disease ﬁngerprints identiﬁed in disease pathways
to interaction networks for 14 organisms to ﬁnd candidate subsys-
tems. Evaluation results of predicted candidate subsystems for the
14 species analyzed in this study are shown in Table 3, including
the proportions of known reference pathways that were recovered
by the pathway prediction method. For instance, 61% of Bos taurus
pathways in Wikipathways were recovered. Table 3 contains the
number of interactions imported from BioGRID and STRING dat-
abases. As shown in Table 3, interaction networks of Bos taurus,
Mus musculus, Rattus norvegicus, Danio rerio, and Escherichia coli
achieved the top ﬁve correctly predicted pathways among the spe-
cies included in this study. The number of individual and summa-
tive interactions shown in Table 3 demonstrates the impact of
importing data from STRING database with regard to size of inter-
action network for the top ﬁve species in terms of proportion of
predicted subsystems nearly matching reference pathways data-
set. Some species had no data in the reference set of pathways im-
ported from WikiPathways. In particular, Schizosaccharomyces
pombe and Sus scrofa had predicted subsystems that could not be
evaluated. For STRING data, zero imported interactions means thatTable 2
Average classiﬁcation accuracy.
Disease
category
Average
speciﬁcity
Average
sensitivity
Overall average
accuracy
Cancer 0.75 1.0 0.87
Infectious disease 0.86 0.82 0.84the speciﬁed threshold of evidence score was not reached or there
were already enough interactions from BioGRID (e.g., Saccharomy-
ces c. S288c has 234,870 BioGRID interactions and thus no addi-
tional STRING interactions were imported). Sus scrofa did not
have any reference pathways in WikiPathways, so no prediction
accuracy could be reported.
Tables 4 and 5 show detailed performance of each species with
respect to individual cancer and infectious diseases. Each column
in Tables 4 and 5 shows the proportion of correctly predicted path-
ways for each of the 14 species analyzed in this study based on
matching ﬁngerprints between disease category speciﬁc and spe-
cies interaction networks. The numbers of correctly predicted
pathways per species were normalized to give proportions such
that each species covered a set of ﬁngerprints for a disease. As
examples of correctly predicted pathways using cancer disease ﬁn-
gerprints, the proposed method successfully recovered 11 out of 16
genes in the androgen signaling pathway (PW: 0000564), ﬁve out
of six genes of the altered canonical Wnt signaling pathway (PW:
0000599) and ﬁve out of six genes in tamoxifen pharmacodynam-
ics pathway (PW: 0000839) from the published Rat Genome Data-
base (RGD) [27].4. Discussion
In silico identiﬁcation of potential model organisms may be a
cost effective ﬁrst step in the study of human diseases. By annotat-
ing genetic pathways with GO terms, subgraph patterns in genetic
pathways can acquire greater generalization capability. This gener-
alization allows for matching with an organism’s interaction net-
work that was also annotated using GO terms. The degree to
which an interaction network of a given model organism covered
subgraph patterns of disease pathways was hypothesized to be a
measure of the suitability of this model organism to study biolog-
ical processes related to human diseases. A signiﬁcant proportion
of the interactions (genetic and physical) used in network con-
struction were predicted interactions (e.g., inferred by genome
context methods or text mining). This allowed for the evaluation
of organisms as potential disease models even with limited curated
interaction data.4.1. Main ﬁndings
The statistics in Tables 3–5 show the range of disease model
suitability for the 14 analyzed organisms in terms of pathways pre-
diction accuracy. The interaction networks of Arabidopsis thaliana
(mouse-ear cress; a plant) and Escherichia coli (a bacterium) per-
formed better than those of Gallus gallus (chicken), Canis lupus
familiaris (dog), or Bos taurus (cow) in predicting pathways using
disease ﬁngerprints of colorectal as well as thyroid cancer (see
Table 4). Additionally, interaction networks of Sacchromyces cerevi-
siae (Baker’s yeast) performed better thanMus musculus (mouse) or
Rattus norvegicus (rat) in predicting pathways using Eppstein-Barr
virus disease ﬁngerprints (see Table 5). These types of ﬁndings are
supported by McGary et al., where organisms such as Sacchromyces
cerevisiae and Caenorhabditis elegans (in contrast to Mus musculus
or Rattus norvegicus) were described as putative model organisms
for human diseases [3].
This study was different from the approach of McGary et al. in
the way that it depends on network structure of genetic pathways
as well as Gene Ontology annotations. The work of McGary et al.
was based on overlapping sets of orthologous genes, and a mathe-
matical formulation based on these sets was used to ﬁnd model
organisms. McGary et al.’s work was based on molecular sequence
information, without using network analysis to rank model
organisms based on predicted subsystems (although McGary
Table 3
Number of interactions and proportions of predicted pathways that correctly matched reference pathways for a given species.
NCBI Taxon ID Species name Number of interactions Proportions of predicted pathways matched to reference pathways
BioGRID STRING Total Cancer Infectious disease
3702 Arabidopsis thalianaa 13,828 0 13,828 0.0419 0.055
4896 Schizosaccharomyces pombeb 17,495 32,505 50,000 – –
6239 Caenorhabditis elegans 6998 0 6998 0 0.004
7227 Drosophila melanogaster 40,153 9848 50,001 0.006 0.012
7955 Danio rerio 112 47,029 47,141 0.171 0.144
9031 Gallus gallus 180 39,337 39,517 0.067 0.063
9598 Pan troglodytes 0 36,756 36,756 0.158 0.153
9615 Canis lupus familiaris 5 33,398 33,403 0.014 0.014
9823 Sus scrofab 1 12,831 12,832 – –
9913 Bos taurus 33 49,967 50,000 0.614 0.192
10090 Mus musculus 4729 45,271 50,000 0.452 0.506
10116 Rattus norvegicus 851 49,163 50,014 0.391 0.289
511145 Escherichia colic 4 49,996 50,000 0.236 0.037
559292 Saccharomyces c. S288cc 234,870 0 234,870 0.023 0.012
a Reference pathways from AraPath database.
b Species without a WikiPathways entry.
c Escherichia coli and Saccharomyces c. S288c were compared to BioCyc reference pathways. All predictions regarding other species were evaluated using WikiPathways.
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discovered in cellular networks of candidate organisms, but that
was a further analysis step of the results and was not a core part
of their described method).
Based on the results shown in Tables 4 and 5, it was also ob-
served that performance of Mus musculus and Rattus norvegicus
models was greatly different in the case of some cancer diseases
(e.g., Renal cell carcinoma and Melanoma) and infectious diseases
(e.g., Pertussis and Epstein-Barr Virus). These results suggest that it
may be worth exploring Danio rerio (for Renal cell carcinoma,
Melanoma, or Pertussis) or Saccharomyces cerevisiae (for Epstein-
Barr Virus) as better disease models for certain diseases. To further
support this ﬁnding, recent studies have proposed Danio rerio as a
potential model organism for cancer [28–30], infectious and im-
mune diseases [31], and in vivo drug discovery [32]. Furthermore,
some genes of Saccharomyces cerevisiae have shown similarity to
Epstein-Barr virus DNA polymerase and be orthologous to human
genes associated with Epstein-Barr virus [33,34]. However, it is
important to note that the plausibility of alternative model organ-
isms might also require the consideration of other features such as
phenotypic properties of these speciﬁc diseases (e.g., do the organ-
isms exhibit an observable disease state phenotype that is alter-
able?) as well as other practical considerations (e.g., availability
of valid wild-types or appropriate inbred species).
4.2. Choice of data resources and annotation scheme
Combining micro-level, molecular function annotations of gene/
protein nodes together with information about semantics inherited
in a graph structure can be a powerful approach to derive new
ﬁndings of relevance to biomedicine. Node annotations might not
be restricted to molecular function annotations of GO. Genes/pro-
teins in pathways and interaction networks with disease-speciﬁc
annotation could be augmented from a variety of knowledge
sources. For example, it may be possible to leverage biobanking
and phenotypic information from Electronic Health Records
(EHR) [35] and clinical data resources to annotate disease genes/
proteins. Indeed, we are currently exploring the potential to do this
in the future, with the goal to develop an EHR knowledge-enriched
model to study disease genes/proteins in the context of real clinical
scenarios.
While GO annotations can be found in gene ontology annota-
tions (GOA) ﬁles of the Gene Ontology database, HPRD was chosen
as a source of GO annotations because it is a manually curated re-
source and GO-compatible database. HPRD initially started withdata from the Online Mendelian Inheritance in Man (OMIM) data-
base [36] that focused on disease related genes [37]. This level of
curation met the scope of this study to learn knowledge from dis-
ease-related genetic pathways.
This study only made use of GO molecular function terms. GO
biological process terms are more diverse (and more speciﬁc) in
characterizing genes/proteins than molecular function terms
(there are nearly 2.5 times more biological process terms than
molecular function terms). For the purposes of this study, molecu-
lar function terms were able to increase the model generalization
(extracted patterns can be matched to GO-annotated interaction
networks), thus not requiring additional biological process terms.
Even though the GO biological process terms were not used in
the model, the KEGG edge annotations (e.g., general process type
such as PPrel and speciﬁc relation types such as activation, expres-
sion and inhibition) do capture semantics of the biological process
that involved two genes/proteins.
Using a major gene/protein interaction database such as Bio-
GRID, which provides a high number of unique interactions among
other major databases [38], can be a limiting factor for predicting
subsystems in many species due to the low number of interactions
for some species in BioGRID database. The use of gene/protein
interactions drawn frommeta-databases such as STRING enhanced
the ability to recover known subsystems by increasing the size of
interaction networks. The number of interactions (per species) im-
ported from BioGRID and STRING databases highlights the impor-
tance of aggregating evidence information about interactions
from large number of sources. For instance, the interaction net-
work of Escherichia coli had only four interactions in BioGRID data-
base. About 50,000 interactions regarding Escherichia coli imported
from STRING enabled the prediction of 23% of Wikipathways refer-
ence pathways of Escherichia coli. For Danio rerio, the interaction
network had only 112 interactions imported from BioGRID.
Importing 47,029 interactions from STRING allowed for 18% pre-
diction accuracy for cancer diseases class and 12% prediction accu-
racy of infectious diseases class. The majority of interactions
imported from STRING regarding Escherichia coli and Danio rerio
was largely supported by evidence scores from predicted interac-
tions (e.g., genome context and text mining).
The contribution of multiple methods for interaction prediction
can be demonstrated by the case of Danio rerio and Escherichia coli
interaction networks constructed using interactions imported from
STRING. As shown in Figs. 6 and 7, about 55% of interaction net-
work constructed for the Danio rerio and about 80% of interaction
network constructed for the Escherichia coli were derived from
Table 4
Detailed performance analysis of 14 Species on cancer diseases ﬁngerprints. Each entry represents proportions of correctly predicted pathways for each species using ﬁngerprints of the indicated disease pathway. These proportions
were calculated by normalized through dividing correctly predicted pathways of a given species by the number of all correctly predicted pathways for the same disease. Bold values indicate best model organism in covering ﬁngerprints
of a disease.
NCBI
Taxon
ID
Species name Cancer Pathway (KEGG ID)
Colorectal
cancer
(hsa05210)
Renal cell
carcinoma
(hsa05211)
Pancreatic
cancer
(hsa05212)
Endometrial
cancer
(hsa05213)
Glioma
(hsa05214)
Thyroid
cancer
(hsa05216)
Basal cell
carcinoma
(hsa05217)
Melanoma
(hsa05218)
Bladder
cancer
(hsa05219)
Chronic
myeloid
leukemia
(hsa05220)
Acute myeloid
leukemia
(hsa05221)
Non-small cell
lung cancer
(hsa05223)
3702 Arabidopsis thaliana 0.018 0.005 0.001 0.004 0 0.014 0 0 0 0 0 0
4896 Schizosaccharomyces
pombe
0 0 0 0 0 0 0 0 0 0 0 0
6239 Caenorhabditis
elegans
0 0 0 0 0 0 0 0 0 0 0 0
7227 Drosophila
melanogaster
0.004 0.001 0 0.002 0 0.001 0 0 0 0 0 0
7955 Danio rerio 0.04 0.459 0.059 0.226 0.07 0.08 0.015 0.449 0.215 0.228 0.077 0.098
9031 Gallus gallus 0.001 0.004 0 0.031 0 0.012 0 0 0 0 0 0
9598 Pan troglodytes 0.03 0.049 0.007 0.084 0.156 0.064 0 0.094 0 0.07 0.092 0.096
9615 Canis lupus familiaris 0.005 0.004 0 0.019 0 0.011 0 0 0 0.008 0.01 0.014
9823 Sus scrofa 0 0 0 0 0 0 0 0 0 0 0 0
9913 Bos taurus 0.002 0 0 0.008 0.001 0 0 0 0 0 0 0
10090 Mus musculus 0.669 0.25 0.395 0.28 0.344 0.416 0.859 0.384 0.439 0.296 0.314 0.351
10116 Rattus norvegicus 0.184 0.229 0.536 0.348 0.428 0.402 0.122 0.072 0.346 0.398 0.508 0.441
511145 Escherichia coli 0.022 0 0 0 0 0 0 0 0 0 0 0
559292 Saccharomyces c.
S288c
0.025 0 0.002 0 0 0 0.005 0 0 0 0 0
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Table 5
Detailed performance analysis of 14 Species on infectious diseases ﬁngerprints. Each entry represents proportions of correctly predicted pathways for each species using ﬁngerprints of the indicated disease pathway. These proportions
were calculated by normalized through dividing correctly predicted pathways of a given species by the number of all correctly predicted pathways for the same disease. Bold values indicate best model organism in covering ﬁngerprints
of a disease.
NCBI
Taxon
ID
Species name Infectious Disease Pathway (KEGG ID)
Bacterial
invasion
epithelium
(hsa05100)
Helico-
bacter
pylori
infection
(hsa05120)
Esche-
richia coli
infection
(hsa05130)
Shigellosis
(hsa05131)
Pertussis
(hsa05133)
Legionel-
losis
(hsa05134)
Leishman-
iasis
(hsa05140)
Chagas
disease
(hsa05142)
Toxoplas-
mosis
(hsa05145)
Tubercu-
losis
(hsa05152)
Hepatitis C
(hsa05160)
Measles
(hsa05162)
Inﬂuenza A
(hsa05164)
HTLV-I
(hsa05166)
Herpes
simplex
(hsa05168)
Epstein-
Barr virus
(hsa05169)
3702 Arabidopsis
thaliana
0.005 0 0 0 0 0 0.006 0.004 0.001 0.002 0.022 0.003 0.021 0.002 0.009 0
4896 Schizosaccharo-
myces pombe
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
6239 Caenorhabditis
elegans
0.001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
7227 Drosophila
melanogaster
0.008 0 0 0 0 0 0.002 0.001 0 0 0.002 0.001 0 0 0.001 0
7955 Danio rerio 0.019 0 0 0.068 0.348 1 0.248 0.136 0.012 0.067 0.161 0.103 0.046 0.065 0.05 0
9031 Gallus gallus 0.005 0 0 0.002 0.001 0 0.013 0.008 0.005 0.006 0.024 0.002 0.001 0.002 0 0
9598 Pan troglodytes 0.019 0 0 0.058 0.158 0 0.083 0.038 0.072 0.055 0.081 0.046 0.033 0.064 0.007 0
9615 Canis lupus
familiaris
0.003 0 0 0.013 0 0 0.006 0.003 0.002 0.004 0.009 0.001 0.001 0.004 0.003 0
9823 Sus scrofa 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
9913 Bos taurus 0.003 0 0 0 0 0 0 0.001 0.007 0.001 0.001 0 0 0 0.001 0
10090 Mus musculus 0.693 1 1 0.638 0.211 0 0.346 0.617 0.624 0.66 0.39 0.596 0.65 0.588 0.793 0.171
10116 Rattus
norvegicus
0.227 0 0 0.221 0.282 0 0.296 0.189 0.265 0.202 0.31 0.247 0.245 0.274 0.125 0
511145 Escherichia coli 0.004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
559292 Saccharomyces
c. S288c
0.014 0 0 0 0 0 0 0.004 0.011 0.002 0 0.001 0.005 0 0.01 0.829
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Fig. 6. Contribution of methods used to predict interactions for Danio rerio.
Fig. 7. Contribution of methods used to predict interactions for Escherichia coli.
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gene neighborhood methods that collectively increased the overall
evidence score above 70%. As has been done by others (e.g., Ferrer
et al. [8] used threshold of >0.5 for an adjusted rand index for
determining the correctness of a pathway), a threshold of 70%
was mainly chosen to imply that more than two thirds of the
genes/proteins in a pathway are found. However, if the Danio rerio
and Escherichia coli networks were constructed only from data im-
ported from major databases, the networks would respectively be
45% and 20% of their potential size. Table 6 shows statistics about
the STRING interactions used in the construction of the Danio rerio
network. While 98% of Danio rerio network links had non-zero
scores for partial evidence derived from other databases, 55% these
partial evidence scores would not pass the 70% threshold and
hence the Danio rerio networks would be 45% of its size. Partial evi-
dence from experimental, gene expression, text mining, and gene
neighborhood methods thus boosted the size of Danio rerio net-
work. The results shown in Table 4 also suggest that, for some spe-
cies, very few known interactions (118 as in the Danio rerio
dataset) were available in BioGRID database. Including interactions
from STRING (mostly predicted interactions) allowed for a wider
coverage of the interaction network. The overall impact of includ-
ing multiple sources resulted in an improvement of overall predic-
tion accuracy for 18% of subsystems discovered by cancer
ﬁngerprints and 12% for infectious disease ﬁngerprints.Table 6
Interactions of Danio rerio interaction network with detailed sources of evidence.
Evidence Method/
Source
Number of STRING links
with non-zero score
Proportion of network
links with non-zero score (%)
Neighborhood 4891 9.7
Fusion 299 0.6
Cooccurence 2219 4.4
Coexpression 22,319 44
Experimental 11,547 23
Other databases 49,103 98
Text Mining 15,149 304.3. Summary of study contributions
There are four major contributions of the methodology devel-
oped in this study for evaluating potential model organisms. First,
it was shown that a model-based method could be used to search
and extract functional structural patterns (disease ﬁngerprints) in
disease pathway graphs. Second, a subgraph pattern matching
algorithm, supported by a simple and memory-efﬁcient indexing
method was shown to be useful for identifying subsystems in
interaction networks using disease ﬁngerprints. Third, this work
leveraged rich knowledge sources (KEGG pathways, BioGRID and
STRING interactions databases that could be annotated with GO)
together with computational mining methods to infer potentially
new knowledge (e.g., novel subsystems of disease). The fourth,
and perhaps most signiﬁcant, way that the methodology presented
here is different from previous studies is that the assessment of
disease model potential was achieved at both the unit level (by
considering molecular function) and system level (by considering
graph structure patterns in pathways). Thus, this approach is dif-
ferent from related studies that used gene orthologue sets as the
basis to assess how an organism was suitable as a model (e.g., most
recently by McGary et al. [3]). The method used in this study com-
plements these types of approaches in two major ways: (1) the
way gene molecular function is used to represent similarity of
genes in different organisms and (2) pathways are predicted using
system-level graph-based methods.
4.4. Study limitations
The methods presented here have a number of limitations re-
lated to decisions about the computational methods, the data re-
sources, and the assumptions made in this study. The EM
algorithm that was used for parameter estimation (see Appendix
A) is known for not guaranteeing optimum solutions. Graphs in
the KEGG pathway datasets were assumed to be independent
and identically distributed data. While it is hard to conﬁrm that
a given pair of pathways sharing a set of genes/proteins is totally
independent, assuming independence of graphs items was for the
purpose of statistical analysis and to make the computation of
the model more tractable. There are a number of alternative re-
sources that might have been used, including Reactome pathways
and molecular networks [39], species-speciﬁc databases such as
Rat Genome Database (RGD) [27] and WormBase [40].
Some limitations are inherent in the datasets chosen for this
study and could have had an impact on the results produced. For in-
stance, signiﬁcant proportions of the interactions in STRING data-
base are predicted interactions and thus there is always a
possibility of errors about predicting two genes/proteins being
genetically or physically interacting. There might be gene set over-
lap between pathway data from Wikipathways, BioCyc, and
AraPath databases with the KEGG human pathways that were used
as design dataset. However, this did not have a signiﬁcant effect on
quality of evaluation procedure for two reasons. First, the method
described in this study did not use any sequence similarity or
homology-based technique to predict pathways similar to those
of humans in other species. Second, the methodology used in this
study relied on the molecular function of genes, not the genes
themselves and therefore, genes in predicted pathways did not nec-
essarily have to be sequence-based homologues of human genes.
Evaluating candidate model organisms at the molecular level is
only one facet for determining the viability of a possible model
organism. Other factors, such as cost and controllability in a lab
environment, also need to be considered. This study aimed to uti-
lize already available resources about potential model organism for
systematic evaluation, without particular consideration of cost or
controllability. Nonetheless, the use of the approach described in
A.R. Nabhan, I.N. Sarkar / Journal of Biomedical Informatics 47 (2014) 178–191 189this study may be one factor that can be combined with cost and
controllability factors to help guide future research on human
diseases.
5. Conclusion
This study proposed a method for the evaluation of species as
models to study human diseases. Disease-related genetic pathways
were functionally and structurally analyzed to uncover character-
istic subgraph patterns. These patterns were then matched to
molecular interaction networks for 14 potential model organisms.
The adequacy of a given species as a potential disease model was
hypothesized to be related to the degree to which interaction net-
works cover disease patterns. The ﬁnding that proportions of cor-
rectly predicted subsystems in Danio rerio (Zebraﬁsh) and
Saccharomyces cerevisiae (Baker’s yeast) interaction networks were
higher than those of two common model organisms Mus musculus
(Mouse) and Rattus norvegicus (Rat) suggests there might be unob-
vious molecular networks in alternative model organisms that
might be relevant to study disease-related processes. The ﬁndings
of this study suggest that a network, system-level approach can be
an effective means to ﬁnd such unobvious networks. The promis-
ing results of this study suggest that the disease ﬁngerprint ap-
proach may be used to analyze pathways across multiple species
and may thus be used to identify model organisms for the study
of human disease related processes.
Appendix A. Model and algorithm for subgraph pattern analysis
of genetic pathways
A.1. Preliminaries and Notations
A graph G consists of a set of vertices V and a set of edges E in
which each edge e 2 E, denoted by e(u,v), links two vertices u,
v 2 V. A subgraph consists of a set of nodes V 0 # V together with
a set of edges E0 # E that links its nodes. In this study, genetic
pathways were modeled as a set of labeled directed graphs.
Deﬁnition A1 (Labeled Graph). A labeled graph G(V,E,LV,LE,
P
V,P
E) has a node labeling function LV: V?
P
V that assigns labels
from a node alphabet set
P
V to nodes and an edge labeling
function LE: E?
P
E that assigns labels from an edge alphabet setP
E to edges. A labeled subgraph g consists of a subset of nodes of G
and edges that link them. Labels of nodes and edges of a subgraph g
are the same as its super graph G.
The node alphabet set
P
V contained GO terms. The edge alpha-
bet set
P
E contained relation types in KEGG disease pathway data-
set. The basic deﬁnition of a labeled graph was extended in two
ways. First, a NULL label e was assigned to gene nodes with no
GO terms associated. Second, an entity could be mapped to more
than one label. Also, edges in a given pathway could be labeled
with more than one relation type.
Disease ﬁngerprints are subgraphs of GO annotated disease
pathways graphs that were are assumed to represent functional
sub-processes that could be characteristics of a disease class such
as immune, infectious, or neurodegenerative disease. Disease
ﬁngerprints are therefore functional structural patterns in GO anno-
tated graphs. To quantify the degree to which a ﬁngerprint was
related to each disease class, a ﬁrst step was to use a utility function
to highlight a set of subgraphs (ﬁngerprints) in a given pathway
graph. This utility function was termed a ‘‘partitioning function.’’
Deﬁnition A2 (Partitioning Function). Let E() denote edge set of a
graph G. A partitioning function p: E(G)? Z assigns an integer to
every edge of G such that edges with the same integer form asubgraph. The set of subgraphs Hp highlighted by a speciﬁc
partitioning function p is deﬁned as Hp ¼ fgij8e 2 EðgiÞ; EðgiÞ #
EðGÞ; pðeÞ ¼ ig:
Fig. 2 illustrates the concept of partitioning. From the above def-
inition, it follows that every edge must be covered by only one sub-
graph (i.e., subgraphs of a given partitioning are edge-disjoint).
There is a big space of partitioning functions for each graph in
the dataset and this space is not known a priori. Searching for good
partitioning functions was thus one of the objectives of this study.
Preventing subgraph overlapping has a useful impact on speed and
memory during search for partitioning for each graph. For instance,
the probability estimation algorithm (presented in the next sec-
tion) does not have to minimize overlapping of subgraphs while
searching for partitionings. To accommodate side effects of this
restriction, the process of identifying disease ﬁngerprints takes
into account information from many hypothesized partitioning
functions for every graph in the dataset. In this study, partitionings
were represented by integer arrays where indices represent edge
identiﬁers and values represent subgraphs to which an edge be-
longs. This compact representation allowed for easy extension of
partitionings by modifying edge-to-subgraph assignments of an
existing partitioning in order to generate new ones. This array rep-
resentation was also helpful in detecting similarity between partit-
ionings (which was useful in minimizing memory requirements of
the application by keeping only one copy of a partitioning among
several equi-probable partitionings).
A.2. Mathematical model
Graphs in the design dataset were assumed to be independent
and identically distributed (iid) data observed from an unknown
probability distribution P(G). The iid data assumption was made
for the purpose of facilitating statistical inference and tomake deci-
sion about properties (e.g., class label) of a graph instance indepen-
dent of other graph instances in the dataset. For each pair of graph G
and disease class C, a probability value was used to quantify the
relation between a graph and its class label. Let the probability va-
lue P(G|C) quantify the characteristics of class C that is observed in
graph G. Modeling this probability value directly can be hard,
mainly because: (1) it is a computationally non-trivial task to deter-
mine if two graph instances are equal using the graph isomorphism
test [19,41]; and (2) due to the data sparseness problem (it is usu-
ally hard to ﬁnd more than one isomorphic instance of the same
graph in a given dataset). An indirect way to model P(G|C) was used
to provide the model with access to GO functional annotations as
well as hidden structural patterns (collectively referred to as ‘ﬁn-
gerprints’) in a given graph. Using the utility of partitioning func-
tion, a more useful probability value P(G,p|C) would involve a
graph instance G, a class label C, and a graph partitioning p that di-
vides G into a set of ﬁngerprints. P(G,p|C) quantiﬁes the probability
of observing structural patterns of class C in graph instance G. There
are many possible partitionings for the same graph instance, and to
take into account all possible structural patterns represented in
these partitionings, the probability value P(G|C) can be expressed as
PðGjCÞ ¼
X
p
PðG;pjCÞ ðA1Þ
Let Hp be the set of subgraphs according to a partitioning func-
tion p of graph G:
Hp ¼ fgij8e 2 EðgiÞ; EðgiÞ # EðGÞ; pðeÞ ¼ ig
Assuming that subgraphs resulting from a partitioning function
are conditionally independent, P(G,p|C) can be written as
PðG;pjCÞ
Y
g2Hp
PðgjCÞ ðA2Þ
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graph g is a characteristic structural pattern of class C. Here, it
should be pointed out that the conditional independence assump-
tion made here is mathematically plausible considering that: (1)
subgraphs in one partitioning do not overlap (i.e., do not share
common edges, according to deﬁnition of p); and (2) this assump-
tion is made for subgraphs within the same partitioning (i.e., it is
local to a speciﬁc partitioning, not for all combinations of sub-
graphs.) For the purpose of probability estimation, counting the
number of instances of a subgraph in all partitionings of graph
dataset is impractical, since it re-introduces the problem of sub-
graph isomorphism [19]. In this study, GO-annotated maximal
paths inside the subgraphs were used to approximate representa-
tion of subgraphs. Each maximal path represented a sequence of
GO annotations of nodes that lay in that maximal path. In case a
node has more than one GO annotation, multiple maximal paths
are generated so that each maximal path has only one GO annota-
tion per node. Then, P(g|C) was calculated approximately as
PðgjCÞ 
Y
a2g
PðajCÞ ðA3Þ
where a denotes a GO-annotated maximal path that connect a sub-
set of nodes inside subgraph g. Using Eq. (A3), the likelihood of a
partitioning and a graph instance given a disease class label can
be written as
PðG;pjCÞ ¼
Y
g2Hp
Y
a2g
PðajCÞ ðA4Þ
and, ﬁnally, P(G|C) can be expressed as
PðGjCÞ ¼
X
p
Y
g2Hp
Y
a2g
PðajCÞ ðA5Þ
Thus, Eqs. (A2)–(A5) casts the problem of searching for disease ﬁn-
gerprints as estimating a conditional distribution of GO annotated
maximal paths given disease classes, while maintaining a set of best
partitionings for each graph instance highlighting disease
ﬁngerprints.
A.3. Probability estimation and searching for best partitionings
For a given pathway design dataset, two data entities need to be
generated: (1) the best scoring partitioning set (that contains
disease ﬁngerprints within each pathway); and (2) the conditional
probability table P(a|C). The generation of each of these two enti-
ties requires the existence of the other, but neither of them exists
with the graph data at the beginning of probability estimation pro-
cess. Therefore, both entities must be generated initially at the
same time, albeit with low likelihood, and probability estimate of
P(a|C) and partitionings likelihood values can be improved
iteratively. Here, the estimation of model parameters h is per-
formed following a maximum likelihood approach using the
Expectation–Maximization (EM) [20,42] algorithm. Model parame-
ters consisted of the probability distribution of maximal paths
given class labels:
h ¼ fPðajCÞg ðA6Þ
There can be a large space of possible values of the parameters h and
the search for best parameter values can be based on maximizing
the likelihood on the graph dataset:
h
^
¼ arg max
h
YN
n¼1
½PhðGnjCnÞ
( )
¼ arg max
h
YN
n¼1
X
p
PhðGn;pjCnÞ
" #( )
; ðA7Þwhere N is the number of graphs in the dataset and Ph(Gn,p|Cn) is
computed by Eq. (A4) and the probability distribution Ph (a/C).
Ph(Gn,p |Cn) represents the probability of a partitioning of a graph
given a class label using a given set of values of parameters h. The
EM algorithm aims at maximizing the likelihood function in Eq.
(A7) while identifying best graph partitionings that highlight key
patterns. Because it was computationally expensive to consider all
possible partitionings for graphs in the probability estimation algo-
rithm, a priority queue of a limited number of highly probable par-
titionings was maintained. In each iteration, searching for new
partitionings extends the set of best partitionings of each graph.
These partitionings are evaluated using Eq. (A4) and the parameter
values h obtained in the previous iteration. An initial set of random
partitionings is generated for each graph in the dataset. Annotated
maximal paths were extracted from each subgraph of a given parti-
tioning and the parameters h are initialized with uniform probabil-
ity values. The EM algorithm consisted of repeated iterations of
E-Step and M-Step. In the E-Step of the algorithm, and for each
graph, maximal path parameter counts are collected from within
partitionings. The count of a parameter in one graph is calculated
using:
cðajC;GÞ ¼
X
p
PðpjG;CÞNða;GÞ
X
j
dða; ajÞdðC;CjÞ ðA8Þ
Here, N(a,G) is the number of times a maximal path a appeared
in G (in different subgraphs of G), and d is the Kronecker’s delta
function. The probability value P(p|G,C) is the normalized parti-
tioning probability conditioned on a graph and a class and is given
by:
PðpjG;CÞ ¼ Pðp;GjCÞP
p0Pðp0;GjCÞ
ðA9Þ
where P(p0,G|C) is given by Eq. (A4). The summation in Eq. (A9) is
over the set of best partitionings that is generated for graph G. Since
this set is limited in size, Eq. (A9) is only an approximation of par-
titioning quality. Multiplying the path-class counts d(a,aj)d(C,Cj) by
partitioning probability P(p|G,C) in Eq. (A8) aimed at weighing each
parameter count according to partitionings quality represented by
P(p|G,C). In the M-step, the maximal path parameters are computed
by normalizing the counts:
PðajCÞ ¼
P
ncðajC;GnÞP
n;acðajC;GnÞ
ðA10Þ
For each iteration of the model training algorithm, a search for
best partitionings is performed using the best parameters h esti-
mated so far. Generating new partitionings from existing partition-
ings can be achieved moving edges from one subgraph to another
subgraph. This way some subgraph patterns can grow while others
can diminish. Fig. 3 illustrates the process of generating a new par-
titioning from an existing one. Both existing and newly generated
partitionings were evaluated using Eq. (A4) based on the most re-
cent parameter values h. In this study, the parameter estimation
algorithm was run four iterations.
In summary, the model training procedure aimed to estimate
the probability distribution P(a|C). As a by-product of this proce-
dure, a set of best partitionings of each graph highlighted the key
subgraph patterns in the dataset. The pattern analysis model de-
scribed above was used to ﬁnd best partitionings in disease path-
ways with nodes annotated with molecular functions. Key
patterns were extracted from best partitionings of pathways to
be matched to sub-networks in gene/protein interaction network
of a species.
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network
Algorithm 1. Matching Subgraph Patterns to Gene/Protein
Interaction Network
Input:
Network index: index, network adjacency matrix, subgraph
pattern: g, V(g) vertex set of g
Process:
Step 1: Initialization
1: for each node v in V(g)
2: initialCandidateMatchingSet(v) = {}
3: for each neighbor node u of v
4: mSet = {}
5: let k (Lv(v), Lv(u))
6: vals = index.get(k)
7: for each x 2 vals
8: mSet.insert(x)
9: initialCandidateMatchingSet(v).insert(mSet)
Step 2: Applying topological constraints
10: for each node v in V(g)
11: let candidateMatchingSet(v) be intersection of all
sets in initialCandidateMatchingSet(v)
12: for each node v in V(g)
13: let S = candidateMatchingSet(v)
14: remove every item i 2 S if i is not linked to any item of
candidate sets of neighbors of node v
15: return {} if S is empty
16: repeat 15–17 until no item can be removed from
candidate sets
Step 3: Generate subnetworks by ﬁnding edges between nodes in
ﬁnal candidateMatchingSet
17: matchedSubNetworks = Array(|V(g)|)
18: Let S be the array of all nodes in V(g)
19: matchedSubNetworks (S[1]) = {}
19: for each network node identiﬁer u in
candidateMatchingSet of node S[1]
20: matchedSubNetworks (S[1]).append({u})
21: for i = 2 to |S| // |S| denotes size of set S
22: partialnetworks =matchednetworks(S[i  1])
23: for each partial network h in partialnetworks
24: for each network node identiﬁer u in
candidateMatchingSet of node S[i]
25: if $ node w 2 h such that u is linked to w in the
interaction network
25: matchednetworks(S[i]).append({u} [ h)
Output: matchedSubNetworks[|S|] // output last element in the
array matchedSubNetworksReferences
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